DST and neurodegenerative disease: The involvement of BPAG1 in neurological diseases is further evidenced by in vivo mice studies that established that BPAG1 mutations resulted in the neurodegenerative disease dystonia musculorum, while its overexpression reversed the diseased phenotype [41,42].